Search Within

Dmitriy Zamarin

  1. "Body Imaging Service"
Formats
  1. Journal Article (14)
  2. Meeting Abstract (10)
Groups
  1. Body Imaging Service (24)
  2. Department of Medicine (24)
  3. GDMT, Medicine (24)
  4. Gynecologic Medicine Service (24)
  5. Gynecology Disease Management Team (24)
  6. Radiology, Department of (24)

More Groups

People
  1. Carol Aghajanian (18)
  2. Roisin O'Cearbhaill (13)
  3. Alexia Iasonos (12)
  4. Qin Zhou (11)
  5. Claire Friedman (9)
  6. Rachel Grisham (9)

More People

Years
  1. 2023 (4)
  2. 2022 (6)
  3. 2021 (1)
  4. 2020 (8)
  5. 2019 (3)
  6. 2018 (1)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Gynecologic Oncology (5)
  3. Clinical Cancer Research (2)
  4. Gynecologic Oncology Reports (2)
  5. Cancers (1)
  6. International Journal of Gynecological Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (8)
  2. Elsevier Inc. (5)
  3. American Association for Cancer Research (2)
  4. Elsevier B.V. (2)
  5. Lippincott Williams & Wilkins (2)
  6. Nature Publishing Group (2)

More Publishers

Results (24)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent ovarian cancer: Final results
    Meeting Abstract

    Grisham, R.; Giri, D.; Henson, M.; Iasonos, A.; Zhou, Q.; McDonnell, A.; Girshman, J.; O'Cearbhaill, R.; Zamarin, D.; Aghajanian, C.
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save
  • Efficacy and safety of pembrolizumab in patients with advanced adrenocortical carcinoma
    Meeting Abstract

    Raj, N. P.; Zheng, Y.; Kelly, V.; Katz, S.; Chou, J. F.; Do, R. K. G.; Capanu, M.; Zamarin, D.; Ariyan, C. E.; Untch, B. R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase I study of concomitant galinpepimut-s (GPS) in combination with nivolumab (nivo) in patients (pts) with WT1+ ovarian cancer (OC) in second or third remission
    Meeting Abstract

    O'Cearbhaill, R. E.; Gnjatic, S.; Aghajanian, C.; Iasonos, A.; Konner, J. A.; Losada, N.; Sarasohn, D.; Rasalan, T.; Tew, W. P.; Zamarin, D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase II trial of enzalutamide in patients with androgen receptor positive (AR+) ovarian, primary peritoneal or fallopian tube cancer and one, two, or three prior therapies
    Meeting Abstract

    Grisham, R. N.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; McGrath, S. P.; O'Cearbhaill, R. E.; Sabbatini, P.; Tew, W. P.; Hyman, D. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save